Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities.
Gkika E, Kostyszyn D, Fechter T, Moustakis C, Ernst F, Boda-Heggemann J, Sarria G, Dieckmann K, Dobiasch S, Duma MN, Eberle F, Kroeger K, Häussler B, Izaguirre V, Jazmati D, Lautenschläger S, Lohaus F, Mantel F, Menzel J, Pachmann S, Pavic M, Radlanski K, Riesterer O, Gerum S, Röder F, Willner J, Barczyk S, Imhoff D, Blanck O, Wittig A, Guckenberger M, Grosu AL, Brunner TB. Gkika E, et al. Among authors: haussler b. Strahlenther Onkol. 2023 Nov;199(11):973-981. doi: 10.1007/s00066-023-02085-7. Epub 2023 Jun 2. Strahlenther Onkol. 2023. PMID: 37268767 Free PMC article.
Secondary Primary Cancer Risk After Radiation Therapy in Rectal Cancer: A Population-Based Cohort Study With Propensity Score Matching.
Schlesinger-Raab A, Schubert-Fritschle G, Kim M, Werner J, Belka C, Wolff H, Agha A, Fuchs M, Friess H, Combs S, Häussler B, Engel J, Halfter K. Schlesinger-Raab A, et al. Among authors: haussler b. Clin Colorectal Cancer. 2023 Dec;22(4):485-495.e3. doi: 10.1016/j.clcc.2023.07.007. Epub 2023 Sep 19. Clin Colorectal Cancer. 2023. PMID: 37838522
[BOT with insulin glargine versus BOT with insulin detemir: comparison of treatment costs in type 2 diabetes based on the results of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study from the German Statutory Health Insurance perspective].
Schädlich PK, Koltermann KC, Dippel FW, Hagenmeyer EG, Häussler B. Schädlich PK, et al. Among authors: haussler b. MMW Fortschr Med. 2010 Oct 14;152 Suppl 3:89-95. MMW Fortschr Med. 2010. PMID: 21595152 Clinical Trial. German. No abstract available.
47 results